Genetically informed lung cancer medicine

被引：50

作者：

Pao, William ^{[1
]}

Iafrate, A. John ^{[2
]}

Su, Zengliu ^{[1
]}

机构：

[1] Vanderbilt Univ, Sch Med, Vanderbilt Ingram Canc Ctr, Dept Med,Div Hematol Oncol, Nashville, TN 37232 USA

[2] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA

来源：

JOURNAL OF PATHOLOGY | 2011年 / 223卷 / 02期

关键词：

lung cancer; signal transduction pathway; gene mutation; protein kinase; targeted therapy; genetic analysis; sequencing; gene fusion; gene rearrangement; SMALL-CELL LUNG; RECEPTOR TYROSINE KINASE; EML4-ALK FUSION GENE; C-MET; PHASE-II; ACQUIRED-RESISTANCE; MUTATIONAL ANALYSIS; SOMATIC MUTATIONS; SIGNALING PATHWAY; PIK3CA GENE;

D O I：

10.1002/path.2788

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Knowledge of tumour mutation status has become increasingly important for the prioritization of targeted therapies for cancer. We review here the major known 'driver' mutations with therapeutic relevance in non-small cell lung cancer. We also discuss a variety of methods now being employed in molecular diagnostic laboratories to detect genetic alterations in lung tumours. A genetically-informed approach to lung cancer medicine is rapidly becoming the standard of care worldwide and should lead to improved outcomes for patients. Copyright (C) 2010 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.

引用

页码：230 / 240

页数：11

共 109 条

[11] AKT1E17K in human solid tumours [J].

Bleeker, F. E. ;

Felicioni, L. ;

Buttitta, F. ;

Lamba, S. ;

Cardone, L. ;

Rodolfo, M. ;

Scarpa, A. ;

Leenstra, S. ;

Frattini, M. ;

Barbareschi, M. ;

Del Grammastro, M. ;

Sciarrotta, M. G. ;

Zanon, C. ;

Marchetti, A. ;

Bardelli, A. .

ONCOGENE, 2008, 27 (42) :5648-5650

[12]

Brose MS, 2002, CANCER RES, V62, P6997

[13] A transforming mutation in the pleckstrin homology domain of AKT1 in cancer [J].

Carpten, John D. ;

Faber, Andrew L. ;

Horn, Candice ;

Donoho, Gregory P. ;

Briggs, Stephen L. ;

Robbins, Christiane M. ;

Hostetter, Galen ;

Boguslawski, Sophie ;

Moses, Tracy Y. ;

Savage, Stephanie ;

Uhlik, Mark ;

Lin, Aimin ;

Du, Jian ;

Qian, Yue-Wei ;

Zeckner, Douglas J. ;

Tucker-Kellogg, Greg ;

Touchman, Jeffrey ;

Patel, Ketan ;

Mousses, Spyro ;

Bittner, Michael ;

Schevitz, Richard ;

Lai, Mei-Huei T. ;

Blanchard, Kerry L. ;

Thomas, James E. .

NATURE, 2007, 448 (7152) :439-U1

[14] Detection of t(2;5) in anaplastic large cell lymphoma - Comparison of immunohistochemical studies, FISH, and RT-PCR in paraffin-embedded tissue [J].

Cataldo, KA ;

Jalal, SM ;

Law, ME ;

Ansell, SM ;

Inwards, DJ ;

Fine, M ;

Arber, DA ;

Pulford, KA ;

Strickler, JG .

AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 1999, 23 (11) :1386-1392

[15] An integrated genomic analysis of lung cancer reveals loss of DUSP4 in EGFR-mutant tumors [J].

Chitale, D. ;

Gong, Y. ;

Taylor, B. S. ;

Broderick, S. ;

Brennan, C. ;

Somwar, R. ;

Golas, B. ;

Wang, L. ;

Motoi, N. ;

Szoke, J. ;

Reinersman, J. M. ;

Major, J. ;

Sander, C. ;

Seshan, V. E. ;

Zakowski, M. F. ;

Rusch, V. ;

Pao, W. ;

Gerald, W. ;

Ladanyi, M. .

ONCOGENE, 2009, 28 (31) :2773-2783

[16]

Cho DC, 2009, J CLIN ONCOL, V27

[17] Identification of novel isoforms of the EML4-ALK transforming gene in non-small cell lung cancer [J].

Choi, Young Lim ;

Takeuchi, Kengo ;

Soda, Manabu ;

Inamura, Kentaro ;

Togashi, Yuki ;

Hatano, Satoko ;

Enomoto, Munehiro ;

Hamada, Toru ;

Haruta, Hidenori ;

Watanabe, Hideki ;

Kurashina, Kentaro ;

Hatanaka, Hisashi ;

Ueno, Toshihide ;

Takada, Shuji ;

Yamashita, Yoshihiro ;

Sugiyama, Yukihiko ;

Ishikawa, Yuichi ;

Mano, Hiroyuki .

CANCER RESEARCH, 2008, 68 (13) :4971-4976

[18] Effects of Erlotinib in EGFR Mutated Non-Small Cell Lung Cancers with Resistance to Gefitinib [J].

Costa, Daniel B. ;

Nguyen, Kim-Son H. ;

Cho, Young C. ;

Sequist, Lecia V. ;

Jackman, David M. ;

Riely, GregoryJ. ;

Yeap, Beow Y. ;

Halmos, Balazs ;

Kim, Joo H. ;

Jaenne, Pasi A. ;

Huberman, Mark S. ;

Pao, William ;

Tenen, Daniel G. ;

Kobayashi, Susumu .

CLINICAL CANCER RESEARCH, 2008, 14 (21) :7060-7067

[19] mToR signaling and drug development in cancer [J].

Dancey, Janet .

NATURE REVIEWS CLINICAL ONCOLOGY, 2010, 7 (04) :209-219

[20] Mutations of the BRAF gene in human cancer [J].

Davies, H ;

Bignell, GR ;

Cox, C ;

Stephens, P ;

Edkins, S ;

Clegg, S ;

Teague, J ;

Woffendin, H ;

Garnett, MJ ;

Bottomley, W ;

Davis, N ;

Dicks, N ;

Ewing, R ;

Floyd, Y ;

Gray, K ;

Hall, S ;

Hawes, R ;

Hughes, J ;

Kosmidou, V ;

Menzies, A ;

Mould, C ;

Parker, A ;

Stevens, C ;

Watt, S ;

Hooper, S ;

Wilson, R ;

Jayatilake, H ;

Gusterson, BA ;

Cooper, C ;

Shipley, J ;

Hargrave, D ;

Pritchard-Jones, K ;

Maitland, N ;

Chenevix-Trench, G ;

Riggins, GJ ;

Bigner, DD ;

Palmieri, G ;

Cossu, A ;

Flanagan, A ;

Nicholson, A ;

Ho, JWC ;

Leung, SY ;

Yuen, ST ;

Weber, BL ;

Siegler, HF ;

Darrow, TL ;

Paterson, H ;

Marais, R ;

Marshall, CJ ;

Wooster, R .

NATURE, 2002, 417 (6892) :949-954

← 1 2 3 4 5 6 7 8 9 10 →